BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 38041233)

  • 1. TGF-β signaling promotes desmoid tumor formation via CSRP2 upregulation.
    Li Y; Fujishita T; Mishiro-Sato E; Kojima Y; Niu Y; Taketo MM; Urano Y; Sakai T; Enomoto A; Nishida Y; Aoki M
    Cancer Sci; 2024 Feb; 115(2):401-411. PubMed ID: 38041233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TGF-β and CTGF are Mitogenic Output Mediators of Wnt/β-Catenin Signaling in Desmoid Fibromatosis.
    Varghese S; Braggio DA; Gillespie J; Toland AE; Pollock R; Mayerson J; Scharschmidt T; Iwenofu OH
    Appl Immunohistochem Mol Morphol; 2017 Sep; 25(8):559-565. PubMed ID: 26894649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expression of CSRP2 encoding the LIM domain protein CRP2 is mediated by TGF-beta in smooth muscle and hepatic stellate cells.
    Herrmann J; Borkham-Kamphorst E; Haas U; Van de Leur E; Fraga MF; Esteller M; Gressner AM; Weiskirchen R
    Biochem Biophys Res Commun; 2006 Jul; 345(4):1526-35. PubMed ID: 16735029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characteristics of cultured desmoid cells with different CTNNB1 mutation status.
    Hamada S; Urakawa H; Kozawa E; Arai E; Ikuta K; Sakai T; Ishiguro N; Nishida Y
    Cancer Med; 2016 Feb; 5(2):352-60. PubMed ID: 26686699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preclinical efficacy of the Wnt/β-catenin pathway inhibitor BC2059 for the treatment of desmoid tumors.
    Braggio DA; Costas C de Faria F; Koller D; Jin F; Zewdu A; Lopez G; Batte K; Casadei L; Welliver M; Horrigan SK; Han R; Larson JL; Strohecker AM; Pollock RE
    PLoS One; 2022; 17(10):e0276047. PubMed ID: 36240209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human microRNA expression in sporadic and FAP-associated desmoid tumors and correlation with beta-catenin mutations.
    Cavallini A; Rotelli MT; Lippolis C; Piscitelli D; Digennaro R; Covelli C; Carella N; Accetturo M; Altomare DF
    Oncotarget; 2017 Jun; 8(26):41866-41875. PubMed ID: 28418912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta modulates beta-Catenin stability and signaling in mesenchymal proliferations.
    Amini Nik S; Ebrahim RP; Van Dam K; Cassiman JJ; Tejpar S
    Exp Cell Res; 2007 Aug; 313(13):2887-95. PubMed ID: 17601559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSRP2 suppresses colorectal cancer progression
    Chen L; Long X; Duan S; Liu X; Chen J; Lan J; Liu X; Huang W; Geng J; Zhou J
    Theranostics; 2020; 10(24):11063-11079. PubMed ID: 33042270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt targets genes are not differentially expressed in desmoid tumors bearing different activating β-catenin mutations.
    Timbergen MJM; Janssen ML; Verhoef C; Grünhagen DJ; Chibon F; Smid M; Sleijfer S; Wiemer EAC
    Eur J Surg Oncol; 2019 Apr; 45(4):691-698. PubMed ID: 30528042
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case.
    Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U
    Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714
    [TBL] [Abstract][Full Text] [Related]  

  • 11. β-catenin (CTNNB1) mutations and clinicopathological features of mesenteric desmoid-type fibromatosis.
    Huss S; Nehles J; Binot E; Wardelmann E; Mittler J; Kleine MA; Künstlinger H; Hartmann W; Hohenberger P; Merkelbach-Bruse S; Buettner R; Schildhaus HU
    Histopathology; 2013 Jan; 62(2):294-304. PubMed ID: 23020601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of
    Guo L; Wang X; Xu B; Lang R; Hu B
    Future Oncol; 2021 Feb; 17(4):435-442. PubMed ID: 33397129
    [No Abstract]   [Full Text] [Related]  

  • 13. Correlation between beta-catenin widespread nuclear expression and matrix metalloproteinase-7 overexpression in sporadic desmoid tumors.
    Matono H; Oda Y; Nakamori M; Tamiya S; Yamamoto H; Yokoyama R; Saito T; Iwamoto Y; Tsuneyoshi M
    Hum Pathol; 2008 Dec; 39(12):1802-8. PubMed ID: 18715618
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological features of 70 desmoid-type fibromatoses confirmed by β-catenin immunohistochemical staining and CTNNB1 mutation analysis.
    An J; Woo HY; Lee Y; Kim HS; Jeong J; Kim SK
    PLoS One; 2021; 16(4):e0250619. PubMed ID: 33914771
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased beta-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors).
    Alman BA; Li C; Pajerski ME; Diaz-Cano S; Wolfe HJ
    Am J Pathol; 1997 Aug; 151(2):329-34. PubMed ID: 9250146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Signal transduction pathway analysis in desmoid-type fibromatosis: transforming growth factor-β, COX2 and sex steroid receptors.
    Mignemi NA; Itani DM; Fasig JH; Keedy VL; Hande KR; Whited BW; Homlar KC; Correa H; Coffin CM; Black JO; Yi Y; Halpern JL; Holt GE; Schwartz HS; Schoenecker JG; Cates JM
    Cancer Sci; 2012 Dec; 103(12):2173-80. PubMed ID: 23035734
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting stem cell behavior in desmoid tumors (aggressive fibromatosis) by inhibiting hedgehog signaling.
    Ghanbari-Azarnier R; Sato S; Wei Q; Al-Jazrawe M; Alman BA
    Neoplasia; 2013 Jul; 15(7):712-9. PubMed ID: 23814483
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypoxia promotes breast cancer cell invasion through HIF-1α-mediated up-regulation of the invadopodial actin bundling protein CSRP2.
    Hoffmann C; Mao X; Brown-Clay J; Moreau F; Al Absi A; Wurzer H; Sousa B; Schmitt F; Berchem G; Janji B; Thomas C
    Sci Rep; 2018 Jul; 8(1):10191. PubMed ID: 29976963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. FAP-related desmoid tumors: a series of 44 patients evaluated in a cancer referral center.
    Colombo C; Foo WC; Whiting D; Young ED; Lusby K; Pollock RE; Lazar AJ; Lev D
    Histol Histopathol; 2012 May; 27(5):641-9. PubMed ID: 22419028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. β-Catenin mutation status and outcomes in sporadic desmoid tumors.
    Mullen JT; DeLaney TF; Rosenberg AE; Le L; Iafrate AJ; Kobayashi W; Szymonifka J; Yeap BY; Chen YL; Harmon DC; Choy E; Yoon SS; Raskin KA; Hornicek FJ; Nielsen GP
    Oncologist; 2013; 18(9):1043-9. PubMed ID: 23960186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.